Pemzek PLUS 8/12.5 mg, Tabletten - 30 Swissmedic Key 62499011 Registration Holder AstraZeneca AG Name Pemzek PLUS 8/12.5 mg, Tabletten Date of registration 06.01.2012 Introduction of Sequence 06.01.2012 ATC-Classification Candesartan and Diuretics (C09DA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 30 Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680624990111 Medication Code Synthetika Pharmacode Disponibility
Composition candesartanum cilexetilum 8 mg, hydrochlorothiazidum 12.5 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 77 mg, magnesii stearas, maydis amylum, macrogolum 8000, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 8 mg Hydrochlorothiazide 12.5 mg
BAG: Active Agent Dose Candesartanum Cilexetil 8 mg Hydrochlorothiazide 12.5 mg
Inactive agents Dose Carmellosum Calcicum Hydroxypropylcellulosum Lactose Monohydrate 77 mg Macrogol 8000 Magnesii Stearas Maydis Amylum Pro Compresso
Source Data was imported : 06.09.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
